Abstract
Both neutralizing antibodies and cytotoxic T-cells are necessary to control a viral infection. However, vigorous T helper responses are essential for their elicitation and maintenance. Here we show that a recombinant replication-deficient Herpes Simplex Virus (HSV)-1 vector encoding the Human Immunodeficiency Virus (HIV)-1 matrix protein p17 (T0-p17) was capable of infecting professional antigen presenting cells (APCs) in vitro and in vivo. The injection of T0-p17 in the mouse dermis generated a strong p17-specific CD4+ T helper response preceding both p17-specific humoral and effector T cell responses. Moreover, we show that T0-p17 infection did not interfere with the endogenous processing of the transgene encoded antigen, since infected APCs were able to evoke a strong recall response in vitro. Our results demonstrate that replication-deficient HSV vectors can be appealing candidates for the development of vaccines able to trigger T helper responses.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antigen-Presenting Cells / immunology
-
Antigen-Presenting Cells / virology*
-
CD4 Antigens
-
CD4-Positive T-Lymphocytes / immunology*
-
Female
-
Gene Products, gag / genetics
-
Gene Products, gag / immunology*
-
Gene Products, gag / metabolism
-
Genetic Vectors*
-
HIV Antibodies / blood
-
HIV Antigens / genetics
-
HIV Antigens / immunology*
-
HIV Antigens / metabolism
-
Herpesvirus 1, Human / genetics*
-
Herpesvirus 1, Human / immunology
-
Herpesvirus 1, Human / pathogenicity
-
Humans
-
Immunization
-
Macrophages, Peritoneal / virology
-
Mice
-
Mice, Inbred BALB C
-
Mutation
-
Recombination, Genetic
-
T-Lymphocytes, Helper-Inducer / immunology*
-
Viral Proteins / genetics
-
Viral Proteins / immunology*
-
Viral Proteins / metabolism
-
Virus Replication
-
gag Gene Products, Human Immunodeficiency Virus
Substances
-
CD4 Antigens
-
Gene Products, gag
-
HIV Antibodies
-
HIV Antigens
-
Viral Proteins
-
gag Gene Products, Human Immunodeficiency Virus
-
p17 protein, Human Immunodeficiency Virus Type 1